Prevention and Management of Osteoradionecrosis in Patients with Head and Neck Cancer Treated with Radiation Therapy
Publication Date: May 1, 2024
Last Updated: May 1, 2024
Management
Summary of Recommendations
Recommendation
Clinical Question 1:
How should ORN be characterized, graded, and reported?
a. Which patients should be considered at high risk for ORN?
b. What is the recommended workup to characterize ORN?
1.1.
ORN of the jaw (mandible, maxilla) should be characterized as a radiographic lytic or mixed sclerotic lesion of bone and/or visibly exposed bone and/or bone probed through a periodontal pocket or fistula, occurring within an anatomical site previously exposed to a therapeutic dose of head and neck radiation therapy. (L, S, Informal Consensus)
3507647
Title
Prevention and Management of Osteoradionecrosis in Patients with Head and Neck Cancer Treated with Radiation Therapy
Authoring Organizations
American Society of Clinical Oncology
Multinational Association of Supportive Care in Cancer